Ethical dilemmas in genetic testing: Examples from the cuban program for predictive diagnosis of hereditary ataxias

Journal of Genetic Counseling

Volumn 20, Issue 3, 2011, Pages 241-248

  Mariño, Tania Cruz ^a,c   Armiñán, Rubén Reynaldo ^a   Cedeño, Humberto Jorge ^a   Mesa, José Miguel Laffita ^a   Zaldivar, Yanetza González ^a   Rodríguez, Raúl Aguilera ^a   Santos, Miguel Velázquez ^a   Mederos, Luis Enrique Almaguer ^a   Herrera, Milena Paneque ^b   Pérez, Luis Velázquez ^a,c  

^a Centro para la Investigacion y Rehabilitacion de las Ataxias Hereditarias Cuba   (Cuba)

^b UNIVERSITY OF PORTO   (Portugal)

^c NONE   (Cuba)

Author keywords

Cuba; Ethical dilemmas; Hereditary ataxias; Predictive testing program; Spinocerebellar ataxia type 2

Indexed keywords

NERVE PROTEIN; SCA2 PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CUBA; ETHICS; FEMALE; GENETIC SCREENING; GENETICS; HETEROZYGOTE DETECTION; HUMAN; MEDICAL ETHICS; MONOZYGOTIC TWINS; PEDIGREE; PREDICTIVE VALUE; PRENATAL DIAGNOSIS; SPINOCEREBELLAR DEGENERATION;

ADOLESCENT; ADULT; CUBA; ETHICS, MEDICAL; FEMALE; GENETIC TESTING; HETEROZYGOTE DETECTION; HUMANS; NERVE TISSUE PROTEINS; PEDIGREE; PREDICTIVE VALUE OF TESTS; PRENATAL DIAGNOSIS; SPINOCEREBELLAR DEGENERATIONS; TWINS, MONOZYGOTIC;

EID: 79958771001     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-010-9347-4     Document Type: Article

References (31)

1. Bondor, B., Kárteszi, J., Hadzsiev, K., Kellermayer, R., Melegh, B., & Kosztolányi, G. (2008). Psychological aspects pf presymptomatic diagnosis in Huntington disease. Orvosi Hetilap, 149, 609-612. (Pubitemid 351513892)
2. Boyle, R. J., & Savulescu, J. (2003). Prenatal diagnosis for "minor" genetic abnormalities is ethical. The American Journal of Bioethics, 3, 60-65.
3. Brown, K. (2008). Genetic counseling legal issues surrounding nondisclosure of paternity. The Journal of Legal Medicine, 29, 345-361.
4. Caenazzo, L., Comacchio, A., Tozzo, P., Rodríguez, D., & Benciolini, P. (2008). Paternity testing requested by private parties in Italy: some ethical considerations. Journal of Medical Ethics, 34, 735-737.
5. Coustasse, A., Pekar, A., & Sikula, A. (2009). Ethical considerations of genetic presymptomatic testing for Huntington's disease. Journal of Hospital Marketing & Public Relations, 19, 129-141.
6. Cruz, M. T., González, Z. Y., Laffita, M. J., Almaguer, M. L., Aguilera, R. R., Almaguer, G. D., et al. (2010a). Uncommon features in Cuban families affected with Friedreich ataxia. Neuroscience Letters, 472, 85-89.
7. Cruz, M. T., González, Z. Y., Laffita, M. J., Almaguer, M. L., Aguilera, R. R., Almaguer, G. D., et al. (2010b). Low predisposition to instability of the Friedreich ataxia gene in Cuban population. Clinical Genetics, 77, 598-600.
8. Draper, H. (2007). Paternity fraud and compensation for misattributed paternity. Journal of Medical Ethics, 33, 475-480.
9. Durr, A., & Viville, S. (2007). Huntington disease: presymptomatic testing, prenatal diagnosis, preimplantation genetic diagnosis experience. Gynécologie, Obstétrique & Fertilité, 35, 1051-1054. (Pubitemid 47576698)
10. Edge, K. (2008). Benefits and potential harms of genetic testing for huntington's disease: a case study. Human Reproduction and Genetic Ethics, 142, 14-19.
11. European Community Huntington Disease Collaborative Study Group. (1993). Ethical and social issues in presymptomatic testing for Huntington's disease: a European community collaborative study. Journal of Medical Genetics, 30, 1028-1035.
12. Gargiulo, M., Lejeune, S., Tanguy, M. L., Lahlou-Laforet, K., Faudet, A., Cohen, D., et al. (2009). European Journal of Human Genetics, 17, 165-171.
13. Hallowell, N., Foster, C., Eeles, R., Ardern-Jones, A., Murday, V., & Watson, M. (2003). Balancing autonomy and responsibility: the ethics of generating and disclosing genetic information. Journal of Medical Ethics, 29, 74-79. (Pubitemid 36511314)
14. Harper, P. S., Lim, C., & Craufurd, D. (2000). Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's disease prediction consortium. Journal of Medical Genetics, 37, 567-571. (Pubitemid 30604092)
15. Lantigua, C. A., Lemus, V. M., & Marcheco, T. B. (2007). Medical genetic services in Cuba. Rev Cubana Genet Comunit, 1, 15-19.
16. Li, D. (2008). Incidental discovery of nonpaternity during prenatal testing of genetic disease. Fetal Diagnosis and Therapy, 24, 39-41.
17. Lucast, E. (2007). Informed consent and the misattributed paternity problem in genetic counseling. Bioethics, 21, 41-50.
18. Lynch, D. R., & Farmer, J. (2002). Practical approaches to neurogenetic disease. Journal of Neuro-Ophthalmology, 22, 297-304. (Pubitemid 35416841)
19. Ohm, K. K., & Derom, C. (2006). Data collection on multiple births - establishing twin registers and determining zygosity. Early Human Development, 82, 357-363.
20. Pandolfo, M. (2009). Friedreich ataxia: the clinical picture. Journal of Neurology, 256, 3-8.
21. Paneque, H. M., Santos, F. N., Tamayo, C. H., Reynaldo, A. R., Velázquez, P. L., Almaguer, M. L., et al. (2001). Type 2 spinocerebellar ataxia: acceptance of prenatal diagnosis in descendents at risk. Revista de Neurologia, 33, 904-908. (Pubitemid 34135525)
22. Paneque, H. M., Lemos, C., Escalona, K., Prieto, L., Reynaldo, R., Velázquez, M., et al. (2007). Psychological follow-up of presymptomatic genetic testing for Spinocerebellar Ataxia type 2 (SCA2) in Cuba. J Genet Counsel, 16, 469-479. (Pubitemid 47305503)
23. Paneque, H. M., Prieto, A. L., Reynaldo, R. R., Cruz, M. T., Santos, F. N., Almaguer, M. L., et al. (2007). Psychological aspects of presymptomatic diagnosis of spinocerebellar Ataxia type 2 in Cuba. Community Genetics, 10, 132-139. (Pubitemid 46944288)
24. Paneque, H. M., Lemos, C., Sousa, A., Velázquez, P. L., Fleming, M., & Sequeiros, J. (2009). Role of the disease in the psychological impact of pre-symptomatic testing for SCA2 and FAP ATTRV30M: experience with the disease, kinship and gender of the transmitting parent. J Genet Counsel, 18, 483-493.
25. Parker, M., & Lucassen, A. (2002). Working towards ethical management of genetic testing. Lancet, 360, 1685-1688. (Pubitemid 35379744)
26. Rolim, L., Lêite, A., Lêdo, S., Paneque, H. M., Sequeiros, J., & Fleming, M. (2006). Psychological issues of genetic testing for Huntington's disease, Machado-Joseph's disease and familial amyloidotic polyneuropathy: a review of literature. Clinical Genetics, 69, 297-305.
27. Sequeiros, J. (1996). Protocolo geral do Programa Nacional de Teste Preditivo e Aconselhamento Genético na Doença de Machado- Joseph. In J. Sequeiros (Ed.), O Teste Preditivo da Doença de Machado-Joseph (pp. 123-149). Porto: UnIGene, IBMC.
28. Tibben, A. (2007). Predictive testing for Huntington's disease. Brain Research Bulletin, 72, 165-171.
29. Turney, L. (2005). The incidental discovery of nonpaternity through genetic carrier screening: an exploration of lay attitudes. Qualitative Health Research, 15, 620-634.
30. Velázquez, P. L., Sánchez, C. G., Santos, F. N., Almaguer, M. L., Escalona, B. K., Rodríguez, L. R., et al. (2009). Molecular epidemiology of spinocerebellar ataxias in Cuba: Insights into SCA2 founder effect in Holguín. Neuroscience Letters, 454, 157-160.
31. Wertz, D. C., & Fletcher, J. C. (2004). Genetics and ethics in global perspective. International library of ethics, law, and the new medicine. The Netherlands: Kluwer Academic Publishers.